🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this project is to evaluate the performance of Picterus Jaundic...
Status
Unknown
Location
Intermountain Health
Start Date
2024-02-12
Trial ID
NCT06329843
Treatments Being Tested
The purpose of this study is to evaluate the repeatability and reproducibil...
Status
Suspended
Location
London Vision Clinic
Start Date
2022-09-01
Trial ID
NCT03473847
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
Summary: Purpose: To compare the safety and efficacy of eyelid treatment w...
Status
Completed
Location
Clínica de Oftalmología de Cali S.A
Start Date
2020-10-15
Trial ID
NCT06278584
Treatments Being Tested
The goal of this clinical trial is to evaluate whether Theracal PT, a resin...
Status
Completed
Location
Ataturk University
Start Date
2023-06-20
Trial ID
NCT06874062
that's comparison between partial and complete pulpotomy techniques in prim...
Status
Unknown
Location
Faculty of dentistry cairo university
Start Date
2021-01-20
Trial ID
NCT04650113
Treatments Being Tested
The primary purpose of this clinical trial is to assess the safety and perf...
Status
Recruiting
Location
VA Loma Linda
Start Date
2026-05-14
Trial ID
NCT07277946
Treatments Being Tested
The purpose of this study is to investigate the effect of Bioptron light th...
Status
Not Yet Recruiting
Location
A specialized surgical hospital in Shebin El-kom
Start Date
2026-07-12
Trial ID
NCT07693478
Treatments Being Tested
This trial is test the dentin hypersenstivity using Giomer based Varnish ve...
Status
Completed
Location
Faculty of dentistry
Start Date
2024-11-20
Trial ID
NCT05981625
Treatments Being Tested
Lupus nephritis (LN) develops in 30-60% of systemic lupus erythematosus (SL...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-01
Trial ID
NCT07505576